Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
Inspection Record
Biomylz Private Limited — FDA 483 Findings
Inspectors Alan A. RiveraThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
The responsibilities and procedures applicable to the quality control unit are not fully followed.
Reserve samples from representative sample lots or batches of drug products selected by acceptable statistical procedures are not examined visually at least once a year for evidence of deterioration.
Your firm failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications, whether or not the batch has already been distributed.
Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.
Your firm failed to maintain buildings used in the manufacture, processing, packing, or holding of drug products in a good state of repair.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Akorn, Inc.2016-11-22 · US FDASimilar to finding 2 The responsibilities and procedures applicable to the quality control unit are not fully followed.
- Indoco Remedies Limited2016-09-04 · US FDASimilar to finding 2 The responsibilities and procedures applicable to the quality control unit are not fully followed.
- Auro Pharmacies Inc.2018-10-24 · US FDASimilar to finding 2 The responsibilities and procedures applicable to the quality control unit are not fully followed.
- SCA Pharmaceuticals, LLC.2018-04-09 · US FDASimilar to finding 2 The responsibilities and procedures applicable to the quality control unit are not fully followed.
- Glenmark Pharmaceuticals Ltd.2018-05-24 · US FDASimilar to finding 2 The responsibilities and procedures applicable to the quality control unit are not fully followed.
A record as of the US FDA document published on 2026-10-22. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.